A selective STAT3 inhibitor used to study JAK/STAT signaling, inflammation and cancer biology.
TargetMol Stattic is a nonpeptidic STAT3 inhibitor that interferes with STAT3 activation, dimerization and nuclear translocation. It is commonly used to investigate JAK/STAT signaling, tumor-cell proliferation, apoptosis, inflammation and immune regulation.
Brand: TargetMol
Catalog number: T6308
Product name: Stattic
Synonym: STAT3 Inhibitor V
CAS number: 19983-44-9
Primary target: STAT3
Reported activity: IC50 approximately 5.1 μM
Product type: Small-molecule signal-pathway inhibitor
Applications: Cancer, inflammation, apoptosis and JAK/STAT pathway research
Available formats: Solid compound and 10 mM DMSO solution
Research use only: Not for human or diagnostic use
Original product link: TargetMol Stattic T6308 TargetMol
Contact Biolterna for current pack sizes, availability and batch-specific analytical documentation.
